INFORMATION FOR
News
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.
Highlights from the 2023 American Society of Hematology Annual Meeting
One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
Discoveries & Impact highlights select scientific discoveries per section across the Department of Internal Medicine...
New research led by Yale Cancer Center scientists shows less than a third of older patients with chronic myeloid leukemia (CML) had optimal laboratory monitoring and only two-thirds were adherent to Tyrosine Kinase Inhibitor (TKI) therapy during the first year after diagnosis. TKI treatment can provide a “functional cure” of the disease for many patients with the disease.
Discoveries & Impact (October 2021)
Discoveries & Impact (August 2021)
Discoveries & Impact (May 2021)
Discoveries & Impact (April 2021)
Discoveries & Impact (March 2021)
Discoveries & Impact (January 2021)